Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 71335-2376

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 71335-2376). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph showing the reduction in blood pressure (BP) in mmHg plotted against Olmesartan Medoxomil dose in mg. The graph displays two lines: one with circles representing systolic BP reduction and another with triangles representing diastolic BP reduction. Both show increasing BP reduction with higher doses, plateauing at around 40 mg for systolic and continuing a gradual rise for diastolic BP.*

FDA Label Image

Label (Lbl713352376)

Label for Olmesartan Medoxomil Tablets, USP 5 mg film-coated oral tablets. The package contains 90 tablets, repackaged by Bryant Ranch Prepack, Inc., and manufactured by Glenmark Pharmaceuticals Limited. The label includes storage instructions, a QR code, barcode, and a note to consult a physician if pregnant.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Olmesartan Medoxomil, showing its molecular arrangement with various rings, functional groups, and bonds as typically depicted in pharmaceutical chemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.